Discovery of Q-Markers in traditional Chinese medicine based on machine learning: Application and verification in Xiaoyao Heji.
- 1State Key Laboratory of Bioactive Molecules and Druggability Assessment/International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Ministry of Education (MOE) of China/Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China.
- 2Guangzhou Key Laboratory of Formula-Pattern of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Jinan University, Guangzhou 510632, China.
- 3State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Lunan Pharmaceutical Group Co., Ltd., Linyi 276006, China.
Abstract
Objective
Identification of quality marker (Q-Marker) is central to the modernization and quality control of traditional Chinese medicine (TCM). Existing methods, though diverse, lack a unified and scalable strategy to address the chemical and pharmacological complexity of TCM prescriptions. This study established a machine learning-driven framework to integrate multi-source data and systematically prioritize Q-Marker, using Xiaoyao Heji (XYHJ), a modern antidepressant formulation derived from Xiaoyao San, as a case study.Methods
Firstly, a dataset of 302 compounds was constructed by summarizing 14 reported Q-Marker discovery strategies and annotated with five core dimensions-compatibility, specificity, measurability, traceability, and effectiveness. Subsequently, five ranking models (RankNet, Random Forest, XGBoost, Linear Regression and K-Nearest Neighbors) were trained with 8-fold GroupKFold cross-validation and evaluated by normalized discounted cumulative gain (NDCG), mean average precision (MAP), and Recall. Thirdly, the optimal model was applied to XYHJ, followed by systematic characterization of chemical profiles, quantitative analysis, drug metabolism and pharmacokinetics (DMPK), quality transitivity, and bioactivity. Finally, Q-Markers were further validated through radar chart modeling, Monte Carlo simulations, and chemometric analyses.Results
Through a comparison of the machine learning models, XGBoost outperformed other models, exhibiting high and stable performance with NDCG, MAP, and Recall values ranging from 0.84 to 0.95. For the first time, the XYHJ prescription was comprehensively evaluated across its chemical profile, DMPK properties, quantitative content, manufacturing traceability, and biological efficacy. Using the optimal XGBoost ranking model, 15 components were screened and ranked, successfully identifying paeoniflorin, albiflorin, and glycyrrhizic acid as critical Q-Marker. The reliability of the ranking approach was further validated by integrating a previously published radar chart model with Monte Carlo simulations with over 10 000 sampling iterations. Furthermore, fingerprint similarity and chemometric analysis demonstrated the effectiveness of these Q-Markers in distinguishing XYHJ produced through different manufacturing processes.Conclusion
This study developed a machine learning-driven ranking framework that unifies multiple Q-Marker discovery strategies. Using XYHJ as a case study, this approach not only enhances its quality control system but also provides a valuable reference for the standardization and modernization of other TCM prescriptions.
Related
- Interpretable machine learning for identifying cost drivers of inpatient traditional Chinese medicine services in a tertiary hospital in China
- Evidence quality assessment of traditional Chinese medicine and integrated traditional Chinese and Western medicine for acute upper respiratory infection in children: an umbrella review of systematic reviews and meta-analyses
- From Parallel Practice to Shared Evidence: Korean Traditional Medicine in Obesity Care
- Traditional Chinese medicine (TCM)-based nanoformulations for cancer therapy: antitumor mechanisms, challenges, and future directions
- Screening traditional Chinese medicine monomers for premature ovarian insufficiency: from network meta-analysis to the effects of a promising candidate on oxidative stress biomarkers
BibTeX
@article{chen2026discovery,
title = {{Discovery of Q-Markers in traditional Chinese medicine based on machine learning: Application and verification in Xiaoyao Heji.}},
author = {Guotao Chen and Jing Hu and Aijing Li and Yu Zeng and Qingmei Mo and Kairui Tang and Jiaxu Chen and Xinsheng Yao and Yongxia Guan and Guimin Zhang and Liangliang He and Zhihong Yao},
journal = {Chinese herbal medicines},
year = {2026},
month = sep,
doi = {10.1016/j.chmed.2026.08.020},
url = {https://europepmc.org/article/MED/42948416},
note = {CC BY},
}
RIS
TY - JOUR
TI - Discovery of Q-Markers in traditional Chinese medicine based on machine learning: Application and verification in Xiaoyao Heji.
AU - Guotao Chen
AU - Jing Hu
AU - Aijing Li
AU - Yu Zeng
AU - Qingmei Mo
AU - Kairui Tang
AU - Jiaxu Chen
AU - Xinsheng Yao
AU - Yongxia Guan
AU - Guimin Zhang
AU - Liangliang He
AU - Zhihong Yao
PY - 2026
DA - 2026/09/02
JO - Chinese herbal medicines
DO - 10.1016/j.chmed.2026.08.020
UR - https://europepmc.org/article/MED/42948416
AB - Objective Identification of quality marker (Q-Marker) is central to the modernization and quality control of traditional Chinese medicine (TCM). Existing methods, though diverse, lack a unified and scalable strategy to address the chemical and pharmacological complexity of TCM prescriptions. This study established a machine learning-driven framework to integrate multi-source data and systematically prioritize Q-Marker, using Xiaoyao Heji (XYHJ), a modern antidepressant formulation derived from Xiaoyao San, as a case study.Methods Firstly, a dataset of 302 compounds was constructed by summarizing 14 reported Q-Marker discovery strategies and annotated with five core dimensions-compatibility, specificity, measurability, traceability, and effectiveness. Subsequently, five ranking models (RankNet, Random Forest, XGBoost, Linear Regression and K-Nearest Neighbors) were trained with 8-fold GroupKFold cross-validation and evaluated by normalized discounted cumulative gain (NDCG), mean average precision (MAP), and Recall. Thirdly, the optimal model was applied to XYHJ, followed by systematic characterization of chemical profiles, quantitative analysis, drug metabolism and pharmacokinetics (DMPK), quality transitivity, and bioactivity. Finally, Q-Markers were further validated through radar chart modeling, Monte Carlo simulations, and chemometric analyses.Results Through a comparison of the machine learning models, XGBoost outperformed other models, exhibiting high and stable performance with NDCG, MAP, and Recall values ranging from 0.84 to 0.95. For the first time, the XYHJ prescription was comprehensively evaluated across its chemical profile, DMPK properties, quantitative content, manufacturing traceability, and biological efficacy. Using the optimal XGBoost ranking model, 15 components were screened and ranked, successfully identifying paeoniflorin, albiflorin, and glycyrrhizic acid as critical Q-Marker. The reliability of the ranking approach was further validated by integrating a previously published radar chart model with Monte Carlo simulations with over 10 000 sampling iterations. Furthermore, fingerprint similarity and chemometric analysis demonstrated the effectiveness of these Q-Markers in distinguishing XYHJ produced through different manufacturing processes.Conclusion This study developed a machine learning-driven ranking framework that unifies multiple Q-Marker discovery strategies. Using XYHJ as a case study, this approach not only enhances its quality control system but also provides a valuable reference for the standardization and modernization of other TCM prescriptions.
SN - 1674-6384
SN - 2589-3610
ER -